Abstract |
Whether patients who have GBS with antibodies to galactocerebroside (Gal-C) and gangliosides (Gal-C-GS-GBS) more often have demyelinating or axonal neuropathy remains controversial. We assessed the electrophysiological data from 16 patients with Gal-C-GS-GBS based on the two established criteria to clarify this issue. In this largest cohort of Gal-C-GS-GBS, eight patients had demyelinating neuropathy and none exhibited axonal neuropathy on either criterion. These data indicated that antibodies to Gal-C, a myelin antigen, might predominantly be associated with demyelinating neuropathy, even in the presence of concomitant antibodies to gangliosides.
|
Authors | Makoto Samukawa, Motoi Kuwahara, Miyuki Morikawa, Rino Ueno, Yukihiro Hamada, Kazuo Takada, Makito Hirano, Yoshiyuki Mitsui, Masahiro Sonoo, Susumu Kusunoki |
Journal | Journal of neuroimmunology
(J Neuroimmunol)
Vol. 301
Pg. 61-64
(12 15 2016)
ISSN: 1872-8421 [Electronic] Netherlands |
PMID | 27823807
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Elsevier B.V. All rights reserved. |
Chemical References |
- Autoantibodies
- Cytokines
- Galactosylceramides
- Gangliosides
- galactocerebroside
|
Topics |
- Action Potentials
(physiology)
- Adult
- Aged
- Aged, 80 and over
- Autoantibodies
(blood)
- Child
- Cytokines
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- Galactosylceramides
(immunology)
- Gangliosides
(immunology)
- Guillain-Barre Syndrome
(blood, diagnosis, physiopathology)
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Mycoplasma pneumoniae
(immunology)
- Neural Conduction
(physiology)
|